v3.26.3
Summary of Significant Accounting Policies and Estimates (Tables)
 9 Months Ended
Sep. 30, 2026
Accounting Policies [Abstract]  
Schedule of Contract Liabilities
The following table shows the changes in the contract liabilities during the period:
(amounts in thousands)
Balance at December 31, 2025$24,492 
Increase in contract liabilities11,125 
Revenue recognized during the period that was included in deferred revenues at the beginning of the period(12,117)
Revenue recognized from performance obligations satisfied within the same period(4,574)
Balance at September 30, 2026$18,926 
Schedules of Concentration of Risk, by Risk Factor Revenue associated with each payer, including its affiliated entities, as a percentage of the Company’s total revenue for the respective period, and accounts receivable balance attributable to each payer, including its affiliated entities, as a percentage of the Company’s total accounts receivable balance at the respective condensed consolidated balance sheet date, are as follows:
% Revenue for the three months ended September 30,% Revenue for the nine months ended September 30,% Accounts receivable as of
Major Payer2026202520262025September 30, 2026December 31, 2025
Payer 135.2%37.7%37.3%43.3%20.7%18.4%
Payer 212.1%21.2%13.8%17.2%21.8%22.6%
Payer 313.9%12.9%14.2%10.9%14.2%*
*Represents major payers below 10.0%.
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used in such measurements were as follows:
As of September 30, 2026
Fair ValueLevel 1Level 2Level 3
Financial assets(amounts in thousands)
Short-term marketable securities$102,059 $102,059 $— $— 
As of December 31, 2025
Fair ValueLevel 1Level 2Level 3
Financial assets(amounts in thousands)
Short-term marketable securities$2,295 $2,295 $— $— 
Schedule of Short-Term Marketable Securities The following is a summary of the Company’s U.S. Treasury Notes, which are classified as available-for-sale securities, as of September 30, 2026:
As of September 30, 2026
Amortized CostGross Unrealized GainGross Unrealized LossEstimated Fair Value
(amounts in thousands)
U.S. Treasury Notes$100,038 $— $(408)$99,630